In vivo, in a leukemia cell line (NB4) xenograft model treated with the anti-cancer agent selenite, tumors show a reduction of LC3-II and an increase of p62/SQSTM1, which is indicative of autophagy inhibition. The gene discussed is SQSTM1; the disease is leukemia.